中国首个诱导多能干细胞（iPSC）衍生细胞疗法治疗帕金森病取得突破性进展。记者今天从上海市东方医院获悉，该院与士泽生物医药（苏州）有限 ...

上海团队牵头完成了我国首例临床级iPSC衍生细胞移植治疗帕金森病。新民晚报记者今日了解到，经过一年的随访，患者运动能力及生活质量较细胞 ...

日前，日本大阪大学研究团队在全球首次使用人体来源的诱导多能干细胞（iPSC）定向分化的角膜上皮细胞片，修复角膜缘干细胞缺乏症视力障碍患者的角膜，并计划于今年启动更大规模临床试验，以评估疗效。相关研究近期发表在国际学术期刊《柳叶刀》上。

Since then, scientists the world over have been seeking to use induced pluripotent stem cells (iPSC) in applications ranging from disease modelling to drug development and regenerative medicine.

AUSTIN, Texas, January 30, 2025--(BUSINESS WIRE)--Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S. Food and Drug ...

BSCC is equipped with basic cell culture equipment such as laminars, incubators, centrifuges and microscopes. The NiPS division is responsible for iPSC differentiation into different brain cell types.